Thu, March 23, 2023

Oren Livnat Maintained (AVDL) at Strong Buy with Increased Target to $14 on, Mar 23rd, 2023

Oren Livnat of HC Wainwright & Co., Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Increased Target from $13 to $14 on, Mar 23rd, 2023.

Oren has made no other calls on AVDL in the last 4 months.



There are 3 other peers that have a rating on AVDL. Out of the 3 peers that are also analyzing AVDL, 0 agree with Oren's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Oren


  • Francois Brisebois of "Oppenheimer" Maintained at Buy with Increased Target to $20 on, Monday, February 27th, 2023
  • Ami Fadia of "Needham" Maintained at Strong Buy and Held Target at $11 on, Friday, February 24th, 2023
  • Chris Howerton of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Wednesday, November 30th, 2022